Minor Surgery in Primary Care
Minor surgery in primary care encompasses a range of procedures including excision of skin lesions, incision and drainage of abscesses, and joint injections, performed under local anaesthesia with appropriate training and governance frameworks.
Key Facts
- Common GP minor surgery procedures: excision of skin lesions, incision and drainage of abscesses, cryotherapy, cautery, joint/soft tissue injections, removal of ingrown toenails
- All excised lesions must be sent for histological examination to exclude malignancy
- Lidocaine 1% (max dose 3mg/kg or 200mg in adults) or lidocaine 1% with adrenaline (max 7mg/kg) for local anaesthesia
- 2-week-wait referral for suspicious skin lesions: asymmetry, irregular border, colour variation, diameter >6mm, evolving (ABCDE criteria for melanoma)
- Cryotherapy (liquid nitrogen): for viral warts, seborrhoeic keratoses, actinic keratoses (pre-malignant)
- Joint injection (corticosteroid + local anaesthetic): for OA flares, tendinopathy, bursitis; max 3-4 injections per year per joint
- Infection rate for minor surgery in primary care: approximately 1-3% (similar to hospital settings)
- Clinical governance: appropriate training, consent, resuscitation equipment, infection control, audit
Overview
Key Facts
Minor surgery is a core GP skill that provides convenient, cost-effective access to procedures in the community. Appropriate patient selection, consent, and clinical governance are essential.
Common Procedures
- Excision/shave biopsy of skin lesions (sebaceous cysts, lipomas, moles, skin tags)
- Incision and drainage of abscesses
- Cryotherapy (viral warts, seborrhoeic keratoses, actinic keratoses)
- Cautery/curettage
- Joint and soft tissue injections
- Ingrown toenail surgery (partial nail avulsion + phenolisation)
- Wound closure (suturing, skin adhesive)
- Ear syringing/microsuction
Training and Governance
- RCGP minor surgery certificate or equivalent training
- Regular CPD and audit
- Appropriate premises, equipment, and resuscitation facilities
- Written consent for all procedures
- Chaperone policy
- Histology pathway for all excised specimens
Clinical Presentation
Pre-Procedure Assessment
- Clinical assessment of lesion/condition
- Determine whether lesion is suitable for GP excision or requires specialist referral
- Assess suitability for local anaesthesia
- Anticoagulation status (warfarin, DOACs - generally safe for minor procedures; do not stop)
- Allergy history (lidocaine allergy very rare)
Indications for GP Excision
- Clinically benign skin lesions: sebaceous cysts, lipomas (<5cm), benign moles, skin tags, dermatofibromas
- Diagnostic excision of atypical lesions (if not suspicious enough for 2-week-wait)
Lesions Requiring 2-Week-Wait Referral (NOT GP Excision)
- Suspected melanoma (ABCDE criteria, dermoscopic concern)
- Suspected SCC (non-healing ulcerated/keratotic nodule)
- Suspected BCC in difficult anatomical site (nose, around eyes, ears)
- Rapidly growing lesions
Red Flags
- ABCDE criteria for melanoma: Asymmetry, Border irregularity, Colour variation, Diameter >6mm, Evolving
- Non-healing skin ulcer >8 weeks - consider SCC
- Pearly papule with telangiectasia - consider BCC
- Hard, fixed subcutaneous lump - consider malignancy
- Lesion growing rapidly - urgent referral
Differential Diagnosis
| Lesion | Features | Management |
|---|---|---|
| Sebaceous cyst (epidermoid) | Punctum, soft, mobile, may become infected | Excision |
| Lipoma | Soft, mobile, subcutaneous, lobulated | Excision if symptomatic |
| Skin tag | Pedunculated, skin-coloured, friction areas | Snip excision, cryotherapy |
| Seborrhoeic keratosis | 'Stuck on' appearance, waxy, well-demarcated | Cryotherapy or curettage |
| Actinic keratosis | Rough, scaly, sun-exposed skin, pre-malignant | Cryotherapy, topical 5-FU, diclofenac gel |
| Melanoma | ABCDE criteria, changing lesion | 2-week-wait referral |
| BCC | Pearly papule, rolled edges, telangiectasia | 2-week-wait referral |
| SCC | Keratotic nodule, ulcerated, sun-exposed area | 2-week-wait referral |
Diagnosis / Investigation
Pre-Procedure
- Clinical examination and documentation (description, measurements, photograph)
- Dermoscopy if trained (for pigmented lesions)
- INR check if on warfarin (safe to proceed if INR <3.5 for minor procedures)
Post-Procedure
- All excised tissue must be sent for histology - this is a critical safety requirement
- Histology result review and patient follow-up
- Further management based on histology (re-excision if incomplete, referral if malignant)
Documentation
- Consent form
- Description of procedure, anaesthesia used, complications
- Specimen sent for histology (labelled and orientated if appropriate)
- Follow-up plan communicated to patient
Management
Local Anaesthesia
- Lidocaine 1% (10mg/mL): max dose 3mg/kg (200mg in 70kg adult = 20mL)
- Lidocaine 1% with adrenaline 1:200,000: max dose 7mg/kg; longer duration; reduces bleeding
- Adrenaline: safe for digits (evidence supports use; traditional teaching of avoiding is outdated)
- Infiltrate slowly with fine needle (25G or 27G); wait 3-5 minutes for effect
Excision Technique
- Mark lesion with skin marker
- Elliptical excision: 3:1 length-to-width ratio; fusiform shape; long axis along Langer lines
- Excision margin: 2mm for benign lesions
- Achieve haemostasis (cautery, pressure)
- Closure: subcuticular or interrupted sutures; Steri-Strips for superficial wounds
- Dressing and wound care instructions
Joint Injection
- Aseptic technique essential (infection risk approximately 1 in 10,000-77,000)
- Triamcinolone acetonide 40mg (large joints) or 10mg (small joints) + lidocaine 1%
- Post-injection flare: occurs in 2-10%; self-limiting
- Advise relative rest for 24-48 hours
- Maximum 3-4 injections per joint per year
Incision and Drainage of Abscess
- Local anaesthetic (field block around abscess; infiltrating into abscess is painful and less effective)
- Cruciate incision over point of maximal fluctuance
- Express pus, break down loculations
- Pack cavity lightly with ribbon gauze
- Send pus for MC&S
- Antibiotics only if cellulitis, systemic infection, or immunocompromised
Referral Criteria
- Any lesion suspicious for malignancy: 2-week-wait dermatology/plastics
- Incomplete excision of BCC/SCC/melanoma on histology: urgent re-referral
- Lesions in cosmetically sensitive areas: consider specialist referral
- Large or deep lipomas (>5cm or subfascial): surgical referral
- Recurrent or complex abscesses: consider underlying cause
Prognosis
- Minor surgery complications: infection 1-3%, haematoma 1-2%, wound dehiscence 1-2%
- Incomplete excision of BCC: recurrence rate 17-38% (vs 1-2% with complete excision)
- Histological surprise (unexpected malignancy on histology): approximately 1-2% of excised lesions
- Joint injection: symptom relief in 60-80% lasting 4-12 weeks; repeated injections may accelerate cartilage loss
- Abscess drainage: cure rate >90% with adequate drainage; recurrence 10-15% (higher with MRSA)
Other Relevant Information
Local Anaesthetic Maximum Doses
| Agent | Max Dose | Volume (1% Solution) |
|---|---|---|
| Lidocaine 1% | 3mg/kg (max 200mg) | 20mL |
| Lidocaine 1% + adrenaline | 7mg/kg (max 500mg) | 50mL |
| Bupivacaine 0.25% | 2mg/kg (max 150mg) | 60mL |
ABCDE Criteria for Melanoma
| Feature | Description |
|---|---|
| A - Asymmetry | Lesion not symmetrical |
| B - Border | Irregular, ragged edges |
| C - Colour | Multiple colours (brown, black, red, white, blue) |
| D - Diameter | >6mm (or any size if changing) |
| E - Evolving | Changing size, shape, or colour |